STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3627 by analyst upside · 2026-08-12
RVTY
Revvity, Inc.
Healthcare · Market Cap $13B · P/E 55.6x
ANALYST PRICE TARGET
+4.6%
implied upside to consensus target
Current Price $115.73
Consensus Target $121.07
Bull Target $145.0
Bear Target $100.0
Analysts Covering 15
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
5
Hold
10
Sell
0
52-Week Low $81.22
52-Week High $118.3
YTD Return +18.1%
FUNDAMENTALS
Market Cap $13B
P/E Ratio (TTM) 55.6x
Forward P/E 19.6x
EPS (TTM) $2.08
PEG Ratio 0.72
Dividend Yield 0.24%
Revenue (TTM) $2.9B
Profit Margin 8.2%
52-WEEK RANGE
52-Week Low $81.22
52-Week High $118.3
Current Price $115.73
Bear Target $100.0
Bull Target $145.0
● Now $115.73 ● Target $121.07
TRADING DATA
Avg Volume 1.5M
YTD Return +18.1%
Analyst Count 15
Consensus Hold
Upside to Target +4.6%
Last Updated 2026-08-12

ANALYST SUMMARY

Revvity, Inc. (RVTY) is currently trading at $115.73 with a Wall Street consensus price target of $121.07, implying potential upside of 4.6% over the next 12 months. 15 analysts currently cover RVTY, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $145.0, while the most cautious has a target of $100.0.

RVTY operates in the Healthcare sector with a market capitalisation of $13B. The stock is up 18.1% year-to-date and is currently trading near the upper end of its 52-week range of $81.22 – $118.3.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for RVTY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Barclays - Reiterated
Equal-Weight → Equal-Weight 2026-05-07 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-05-06 43% win rate (7 calls)
TD Cowen - Reiterated
Buy → Buy 2026-05-06 Building track record
Stifel - Reiterated
Hold → Hold 2026-05-06 Building track record
Baird - Reiterated
Outperform → Outperform 2026-05-04 Building track record
Goldman Sachs - Reiterated
Neutral → Neutral 2026-04-14 Building track record
Barclays ↓ Downgrade
Overweight → Equal-Weight 2026-04-14 Building track record
JP Morgan - Reiterated
Neutral → Neutral 2026-03-31 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
45
out of 100
Coverage depth
21/30
Consensus clarity
22/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →